Rabdomiolisis por levetiracetam
نویسندگان
چکیده
منابع مشابه
Levetiracetam.
Levetiracetam (LEV) is a novel antiepileptic drug (AED) which was discovered in early 1980s and soon, in 1999 FDA approved LEV for the management of partial onset seizure. In India, LEV tablet was approved in April 2005. It acts by binding to the synaptic vesicle protein SV2A, which is present on synaptic vesicles and some neuroendocrine cells. Pharmacokinetics of LEV such as, less protein bind...
متن کاملLevetiracetam and psychosis.
We present the case of a 45-year old woman diagnosed of partial complex epilepsy from childhood that was stabilized with carbamazepine 400 mg/day over all the years. Due to the decrease in libido secondary to this drug, she began to have problems in her personal life so that her attending neurologist decided to switch her to levetiracetam 1500 mg/day. Two months after the change in anti-epilept...
متن کاملLevetiracetam-associated hyponatremia
Hyponatremia has been associated with several antiepileptic drugs (AEDs), such as carbamazepine, oxcarbazepine, and occasionally with valproate and lamotrigine. 1,2 To date, there is only a report of hyponatremia associated with levetiracetam in a 65-year-old patient predisposed to the development of syndrome of inappropriate antidiuretic hormone secretion (SIADH). 3 We recently observed a pati...
متن کاملLevetiracetam-induced pancytopenia
Pancytopenia is a rare side effect of levetiracetam (LEV) that is associated with severe morbidity that requires hospitalization. Here, we report a patient with a right temporoparietal tumor who underwent a temporal craniotomy with resection of the mass and was started on LEV for seizure prophylaxis per the neurosurgery local protocol. The patient developed LEV-induced pancytopenia, which was s...
متن کاملZonisamide, Topiramate, and Levetiracetam
The anticonvulsant topiramate not only decreases ethanol consumption in alcohol dependence (AD) but also may produce several adverse events including cognitive impairment. Zonisamide is a structurally related anticonvulsant that is a promising agent for the treatment of AD and may have greater tolerability than topiramate. This study evaluated the effects of zonisamide (400 mg/d) on alcohol con...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Médica Colombiana
سال: 2019
ISSN: 2248-6054,0120-2448
DOI: 10.36104/amc.2018.1363